Oncolys BioPharma Inc. (TYO:4588)

Oncolys BioPharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 23, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	185,760	12,881	10,878	9,130	9,171	21,971
Market Cap Growth	917.15%	18.41%	19.14%	-0.44%	-58.26%	-19.57%
Enterprise Value	183,373	11,569	9,991	7,125	5,757	20,418
Last Close Price	6300.00	518.00	567.00	527.00	528.00	1503.00

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 23, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
PS Ratio	6507.40	410.43	172.56	9.35	14.27	69.93
PB Ratio	104.90	4.68	7.38	4.23	2.55	10.97
P/TBV Ratio	104.90	4.68	7.38	4.23	2.55	10.97

EV Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 23, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
EV/Sales Ratio	-	368.62	158.50	7.30	8.96	64.99

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 23, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Debt / Equity Ratio	0.19	0.12	0.21	0.18	0.14	0.26
Net Debt / Equity Ratio	-0.57	-0.76	-0.83	-0.61	-0.82	-0.77
Net Debt / EBITDA Ratio	0.50	1.24	0.63	1.08	1.95	0.92
Net Debt / FCF Ratio	-	1.03	0.91	0.77	1.69	1.05
Asset Turnover	0.01	0.01	0.03	0.28	0.18	0.09
Inventory Turnover	-	-	2.19	35.52	40.10	6.15
Quick Ratio	5.19	10.14	4.32	6.19	8.91	5.38
Current Ratio	6.62	12.28	5.17	8.11	9.76	6.13
Return on Equity (ROE)	-110.09%	-79.73%	-106.71%	-39.94%	-57.72%	-76.78%
Return on Assets (ROA)	-55.37%	-40.26%	-51.44%	-22.01%	-26.86%	-29.41%
Return on Invested Capital (ROIC)	-345.38%	-365.97%	-351.64%	-164.69%	-276.12%	-306.97%
Return on Capital Employed (ROCE)	-108.70%	-57.30%	-116.20%	-52.50%	-39.40%	-70.90%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 23, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Earnings Yield	-1.31%	-13.08%	-17.82%	-12.58%	-17.61%	-9.54%
FCF Yield	-1.04%	-15.71%	-12.34%	-18.82%	-19.01%	-6.68%
Buyback Yield / Dilution	-21.76%	-22.67%	-2.71%	-2.44%	-17.54%	-3.41%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error